Ibsrela 50 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DR26F12XE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,447
Award facts
- Contract value 100% obligated
- $5,446.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,446.74 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Through its comprehensive IDC vehicle, the company provides a broad portfolio of pharmaceutical products including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. This delivery order for IBSRELA tablets exemplifies the company's role as a major supplier within the DLA's pharmaceutical supply chain and reflects the agency's strategy of leveraging prime vendor relationships to ensure reliable access to essential medications for the federal healthcare system.
Quick answers
Who was awarded contract SPE2DR26F12XE?
SPE2DR26F12XE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26F12XE worth?
The government has obligated $5,447 on SPE2DR26F12XE.
Is contract SPE2DR26F12XE an order under another contract?
Yes. SPE2DR26F12XE is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F12XE competed?
The extent of competition for SPE2DR26F12XE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award